Page last updated: 2024-11-04

sibutramine and Hyperprolactinemia

sibutramine has been researched along with Hyperprolactinemia in 1 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research Excerpts

ExcerptRelevanceReference
" She started sibutramine treatment and presented with amenogalactorrhea."7.77A case of sibutramine-induced hyperprolactinemia. ( da Costa Oliveira, M; Pereira-Lima, JF; Soares Leaes, CG, 2011)
" She started sibutramine treatment and presented with amenogalactorrhea."3.77A case of sibutramine-induced hyperprolactinemia. ( da Costa Oliveira, M; Pereira-Lima, JF; Soares Leaes, CG, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soares Leaes, CG1
Pereira-Lima, JF1
da Costa Oliveira, M1

Other Studies

1 other study available for sibutramine and Hyperprolactinemia

ArticleYear
A case of sibutramine-induced hyperprolactinemia.
    Neuro endocrinology letters, 2011, Volume: 32, Issue:5

    Topics: Adult; Amenorrhea; Appetite Depressants; Cyclobutanes; Diagnosis, Differential; Female; Galactorrhea

2011